{"response": {"meta": {"time": 41, "hits": 1, "offset": 0}, "docs": [{"news_desk": "Foreign Desk", "document_type": "article", "_id": "4fd242c48eb7c8105d7dc30d", "headline": {"main": "Cosmetic Saves a Cure for Sleeping Sickness"}, "pub_date": "2001-02-09T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By DONALD G. McNEIL Jr", "person": [{"middlename": "G.", "organization": "", "role": "reported", "qualifier": "Jr", "rank": 1, "firstname": "Donald", "lastname": "McNEIL"}]}, "abstract": "Cure for sleeping sickness, disease devastating parts of central Africa, may soon be available cheaply because it has second, profitable use: elimination of facial hair in women; drug, eflornithine, was abandoned by drug companies after early hope that it would help fight cancer was dashed; current shortage is cited by critics of industry who say multinational drug companies ignore the poor; now Bristol-Myers Squibb Co and Gillette Co have introduced eflornithine in facial cream, Vaniqa, and Bristol-Myers is near agreement with World Health Orgn and Doctors Without Borders for companies to make injectable form to treat sleeping sickness; eflornithine is so effective at reviving even comatose patients that it is known as resurrection drug (M)", "web_url": "http://www.nytimes.com/2001/02/09/world/cosmetic-saves-a-cure-for-sleeping-sickness.html", "section_name": "World; Front Page; Health", "lead_paragraph": "A cure for sleeping sickness, a disease devastating parts of central Africa, may soon be available cheaply because it has a second, profitable use: it eliminates facial hair in women. The drug, eflornithine, is so effective at reviving even comatose patients that it is known as the resurrection drug.", "snippet": "A cure for sleeping sickness, a disease devastating parts of central Africa, may soon be available cheaply because it has a second, profitable use: it eliminates facial hair in women.    The drug, eflornithine, is so effective at reviving even...", "blog": [], "keywords": [{"value": "AFRICA", "name": "glocations"}, {"value": "DOCTORS WITHOUT BORDERS", "name": "organizations"}, {"value": "WORLD HEALTH ORGANIZATION", "name": "organizations"}, {"value": "BRISTOL-MYERS SQUIBB CO", "name": "organizations"}, {"value": "GILLETTE CO", "name": "organizations"}, {"value": "SLEEPING SICKNESS", "name": "subject"}, {"value": "VANIQA (DRUG)", "name": "subject"}, {"value": "EFLORNITHINE (DRUG)", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "WOMEN", "name": "subject"}, {"value": "HAIR", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 952, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}